Table 5.

Adverse effects of ketoconazole in Cushing’s disease patients treated with ketoconazole.

	Controlled/partially controlled	Uncontrolled	p
AST	70 ± 230 (12–1,128)	59 ± 90 (15–244)	0.608
ALT	97 ± 341 (16–1,665)	112 ± 214 (17–550)	0.871
Intolerance (Y/N)	3/22 (12/88%)	1/7% (12.5–87.5%)	0.97

AST, aspartate transaminase; ALT, alanine aminotransferase.